"paper"

I would like to express my deepest gratitude to the European Academy of Neurology for having granted my research training Fellowship at the Neurodegeneration Imaging Group (NIG; www.nig-politis.com), based at the Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology & Neuroscience at King’s College London, UK. The NIG is headed by Professor Marios Politis, who is leading expert in the field of neuroimaging in neurodegenerative diseases.

Global Health – EFNA activities update At EFNA we remain engaged with global health initiatives and actors (you can read about initial reasons for this here: Health is a shared global value). The last couple of months have been rather… Continue Reading

Between the 25th and 28th of September 2019, the German Neurological Society (deutsche Gesellschaft für Neurologie – DGN) held its annual congress at the International Congresscenter in Stuttgart, Germany. As one of the largest neurological gatherings in Europe it was attended by approximately 5,500 health professionals associated with Neurology.

The 11th Regional Teaching Course (RTC) in sub-Saharan Africa (SSA) took place in Accra, Ghana. Dr. A. Charway Felli, President-elect of AFAN hosted the RTC held at the Ghana College of Physicians and Surgeons.

Levetiracetam and NOACs

Under the umbrella of the Women’s Brain Project (WBP), the second international Forum on Women’s Brain and Mental Health was held in Zurich (Switzerland) on June 8-9, 2019.

Founded in1996, the European Institute of Women’s Health (EIWH) is a non-governmental organisation (NGO) and registered charity. The Institute uses an evidence-based approach to advocate for equitable, sex- and gender-sensitivity in health policy, research, promotion, treatment and care.  It also promotes biomedical and socio-economic research that addresses sex and gender-based differences to ensure access to quality treatment and care for women across their lifespan. 

Interview with Prof. Claudio Baracchini - President of the ESNCH Prof. Dafin Muresanu interviews President of the ESNCH, Prof. Claudio Baracchini

It is my great pleasure to be invited to introduce myself to you in my new role as editor of EAN Pages, starting at our Congress in Oslo. I am a neurologist based in Sheffield in the UK, running busy general and neuromuscular clinics, with a research interest in motor neuron disease. First of all, I want to thank my predecessor and friend, Professor Elena Moro, for leading us to our current position of strength at EAN Pages.

The last day of the Congress and time to take stock. Kell Morten Myhr summarised the field of multiple sclerosis (MS), which received 205 abstracts. Professor Myhr started his highlights with papers by Persson et al from Lexington reporting longitudinal observational survival data in MS and Stahmann et al from Hanover who reported variable rates of starting disease-modifying therapy. Professor Myhr considered that these papers together pointed toward a need to start MS therapy early. Prognostic blood biomarkers were then considered with vitamin D shown to predict long-term disability (Wesnes et al, Trondheim), whilst neurofilament light chain was associated with development of cognitive impairment in secondary progressive MS (Kuhle et al, Basel).

June 2019 marks the fifth year since the foundation of the European Academy of Neurology (EAN) with the purpose of promoting excellence across the region.

Petr Mikulenka, MD, from Prgaue, Czechia Fellowship Term:  18.06 - 27.07.2018 Hosting department: Department of Neurology, Atkinson Morley Wing, St George’s Hospital, Blackshaw Road, Tooting, London SW17 0QT Supervisor: Dr. Anthony Pereira, Consultant Neurologist

The Norwegian population is small, stable, and well organized. Despite having seen increasing urbanization and immigration in recent years, the population of 5.3 million inhabitants is remarkably stable. Specialist health services are close to 100 % publicly financed and equally available to all. All inhabitants have unique Personal Identification Numbers and can easily be identified across a broad range of mandatory and voluntary public registries. Seventeen central, mandatory health registries are being used for health analysis and statistics, quality improvement, research, administration and emergency preparedness. These include the Medical Birth Registry of Norway, Norwegian Cause of Death Registry, Norwegian Patient Registry and Norwegian Prescription Database.

The award was introduced by Dystonia Europe in 2003 and is presented every two years to stimulate research on dystonia, especially by young scientists in Europe.

The European Parliament Interest Group on Mental health, Well-being and Brain Disorders (with co-hosting MEPs Tomas Zdechovsky and Nessa Childers), EBC, GAMIAN-Europe, the European Psychiatric Association (EPA), EUFAMI, the Expert Platform on Depression, Eurocarers, the European College of Neuropsychopharmacology (ECNP), the UEMS – Sector of Psychiatry and the International Federation for Psychotherapy have launched a joint policy paper on major depression, entitled ‘A sustainable approach to depression: moving from words to actions’, at the European Parliament in Brussels.